LON:HZD - Horizon Discovery Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 166 -4.00 (-2.35 %) (As of 03/22/2019 12:06 PM ET)Previous CloseGBX 170Today's RangeGBX 163 - GBX 167.5052-Week RangeGBX 128 - GBX 252Volume24,990 shsAverage Volume258,981 shsMarket Capitalization£249.70 millionP/E Ratio-25.94Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Horizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments. Its core capabilities are built around its proprietary transnational genomics platform, a suite of gene editing tools to alter gene sequence in human or mammalian cell-lines. The company offers various research products, including cell lines that help researchers to understand how complex genetic diseases manifest themselves in patients; research reagents, which enable researchers to silence genes with the use of RNAi and express or overexpress genes through tools, such as cDNA, as well as permanently edit genes with CRISPR reagents; and in vivo research models for specialized R&D applications, and to support preclinical drug development programs. It also provides reference standards that are used as a source of genetically defined, quantitative, sustainable, and independent third-party reference material, as well as for validation and routine performance monitoring of assays; and bio-production cell lines licenses. In addition, the company offers cell and in vivo custom model generation, assay, and genetic and molecular screening services, as well as screening publications. Further, it is involved in the leverages R&D activity. The company serves customers in academic research, drug discovery and manufacturing, and clinical diagnostics markets. It sells its products through direct sales channel and e-commerce platform. The company has a target discovery partnership with C4X Discovery Holdings plc to validate novel synthetic oncology targets. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom. Receive HZD News and Ratings via Email Sign-up to receive the latest news and ratings for HZD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:HZD Previous Symbol CUSIPN/A CIKN/A Webwww.horizondiscovery.com Phone+44-1223-976000Debt Debt-to-Equity RatioN/A Current Ratio4.30 Quick Ratio4.06Price-To-Earnings Trailing P/E Ratio-25.94 Forward P/E Ratio-40.79 P/E GrowthN/A Sales & Book Value Annual Sales£49.52 million Price / Sales5.04 Cash FlowGBX 16.48 per share Price / Cash Flow10.07 Book ValueGBX 111.90 per share Price / Book1.48Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares150,424,000Market Cap£249.70 million Next Earnings DateN/A OptionableNot Optionable Horizon Discovery Group (LON:HZD) Frequently Asked Questions What is Horizon Discovery Group's stock symbol? Horizon Discovery Group trades on the London Stock Exchange (LON) under the ticker symbol "HZD." What price target have analysts set for HZD? 2 equities research analysts have issued 1 year price targets for Horizon Discovery Group's stock. Their forecasts range from GBX 177 to GBX 245. On average, they anticipate Horizon Discovery Group's stock price to reach GBX 211 in the next year. This suggests a possible upside of 27.1% from the stock's current price. View Analyst Price Targets for Horizon Discovery Group. What is the consensus analysts' recommendation for Horizon Discovery Group? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horizon Discovery Group in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Horizon Discovery Group. Has Horizon Discovery Group been receiving favorable news coverage? Media headlines about HZD stock have trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Horizon Discovery Group earned a daily sentiment score of 0.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. Who are some of Horizon Discovery Group's key competitors? Some companies that are related to Horizon Discovery Group include Mesoblast (MSB), Resverlogix (RVX), Emerald Health Therapeutics (EMH), Theratechnologies (TH), Biotest (BIO), Polynovo (PNV), Senesco Technologies (ELOX), Oxford BioMedica (OXB), Starpharma (SPL), Neptune Wellness Solutions (NEPT), IMV (IMV), Enochian Biosciences (ENOB), Monash IVF Group (MVF), Kodiak Sciences (KOD) and Emblem (EMC). What other stocks do shareholders of Horizon Discovery Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Discovery Group investors own include Yamana Gold (YRI), Silvercorp Metals (SVM), Barkerville Gold Mines (BGM), Polo Resources (POL), Faron Pharmaceuticals Oy (FARN), Eldorado Gold (ELD), Eastside Distilling (EAST), Red Rock Resources (RRR), First Majestic Silver (AG) and Alamos Gold (AGI). Who are Horizon Discovery Group's key executives? Horizon Discovery Group's management team includes the folowing people: Mr. Richard John Vellacott, CFO & Director (Age 44)Mr. Terence William Pizzie, CEO & Director (Age 58)Dr. Chris Torrance, Co-Founder & Member of Scientific Advisory BoardProf. Alberto Bardelli Ph.D., Co-Founder & Chairman of Scientific Advisory BoardMs. Kim Nichols, Head of Global Operations How do I buy shares of Horizon Discovery Group? Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Horizon Discovery Group's stock price today? One share of HZD stock can currently be purchased for approximately GBX 166. How big of a company is Horizon Discovery Group? Horizon Discovery Group has a market capitalization of £249.70 million and generates £49.52 million in revenue each year. What is Horizon Discovery Group's official website? The official website for Horizon Discovery Group is https://www.horizondiscovery.com/. How can I contact Horizon Discovery Group? Horizon Discovery Group's mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000. MarketBeat Community Rating for Horizon Discovery Group (LON HZD)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 403 (Vote Outperform)Underperform Votes: 258 (Vote Underperform)Total Votes: 661MarketBeat's community ratings are surveys of what our community members think about Horizon Discovery Group and other stocks. Vote "Outperform" if you believe HZD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HZD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: How Does the Quiet Period Work?